| Predicate |
Object |
| contentType |
Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't |
| endingPage |
1298 |
| issn |
1098-3015 |
| issueIdentifier |
10 |
| pageRange |
1288-1298 |
| publicationName |
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research |
| startingPage |
1288 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5c1b1599605c1981e7e6fe36034de310
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d13e91654776bdcedac32997816d3dcd |
| bibliographicCitation |
Laxy M, Wilson ECF, Boothby CE, Griffin SJ. Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data. Value in Health. 2017 Dec;20(10):1288–98. doi: 10.1016/j.jval.2017.05.018. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ce198bf8c90b2e51f0d11403a90fccf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5288b3892909ec9cd9ad674442a33ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21b1072a0d11ae3a0944cf8adb18f857
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acfc31fd7f719374ce71a27a20e2a679 |
| date |
201712 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC6086325
https://doi.org/10.1016/j.jval.2017.05.018
https://pubmed.ncbi.nlm.nih.gov/29241888 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1098-3015
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26775 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011320Q000379
http://id.nlm.nih.gov/mesh/D003924Q000628
http://id.nlm.nih.gov/mesh/D008403Q000379
http://id.nlm.nih.gov/mesh/D019057 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011320Q000191
http://id.nlm.nih.gov/mesh/D016014
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D017048
http://id.nlm.nih.gov/mesh/D003924Q000175
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D003362
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D003924Q000191
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D006113 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 |